This product is strictly for laboratory research purposes only
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Sterile water, on the other hand, is just thatsterile water with no preservative
After 28 days, bacterial growth risk increases even with bacteriostatic water, and peptide degradation becomes significant
D51.2 Transcobalamin II Deficiency Use for congenital transcobalamin II deficiency, a rare inherited disorder diagnosed in infancy
Impaired balance and coordination, trouble walking